Dexamethasone-sparing regimens with NEPA (netupitant/palonosetron) for the prevention of chemotherapy-induced nausea and vomiting in older patients (>65 years) fit for cisplatin: A sub-analysis from a phase 3 study [PDF]
, 2023 Luigi Celio, Rupert Bartsch, Matti Aapro
openalex +1 more source
The FASEB Journal, Volume 39, Issue 19, 15 October 2025.Glioblastoma (GBM), a neuroepithelial‐derived lethal malignancy, remains incurable due to its intrinsic heterogeneity, necessitating molecular biomarkers for precision therapeutics. STC1 promotes GBM progression and temozolomide (TMZ) resistance by activating the NF‐κB signaling pathway, which drives epithelial–mesenchymal transition (EMT) and enhances
Jia Wang +7 more
wiley +1 more source
One-Day Versus Three-Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data-Based Meta-Analysis [PDF]
, 2019 Yuki Okada +8 more
openalex +1 more source
The effect of Citrus aurantium inhalation aromatherapy on chemotherapy-induced nausea and vomiting in breast cancer patients: a randomized controlled trial. [PDF]
BMC Complement Med TherTabei P +4 more
europepmc +1 more source
Acupuncture as a Complementary Therapy in Chemotherapy-Induced Nausea and Vomiting
, 2009 Ling Ma
openalex +2 more sources
Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial [PDF]
, 1995 Vittorio Gebbia +5 more
openalex +1 more source
Factors affecting chemotherapy-induced nausea and vomiting in patients with lung squamous cell carcinoma. [PDF]
Am J Transl ResWang J.
europepmc +1 more source
Chemotherapy-Induced Nausea and Vomiting #285
, 2014 Nishant Tageja, Hunter Groninger
openalex +2 more sources